Clinical trial
Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally…
NCT00467259 · Warner Chilcott, Industry · Completed
Key facts
| NCT number | NCT00467259 |
|---|---|
| Title | Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women |
| Official title | A Randomized, Double-Blind, Placebo-controlled, Multicenter, 52-week Study to Evaluate the Endometrial Safety of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women With Hypoactive Sexual Desire Disorder. |
| Lead sponsor | Warner Chilcott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypoactive Sexual Desire Disorder |
| Intervention type | Drug |
| Interventions | Testosterone Transdermal System, Placebo patch |
| Enrollment | 1,271 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Apr 30, 2007 |
| Last update posted | Dec 15, 2011 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: